Indication

Skin and skin structure Serratia infection

A skin and skin structure Serratia infection is a bacterial infection of the epidermis, dermis, or deeper subcutaneous tissues caused by species of the genus *Serratia*, most frequently the opportunistic Gram-negative bacillus *Serratia marcescens*. Read more about Skin and skin structure Serratia infection

104 drugs 49 manufacturers

Advertisement

Drugs that treat it

Common Skin and skin structure Serratia infection therapies.

Showing 37–45 of 104 drugs

Filter & compare in the drug finder →Opens the drug finder with Skin and skin structure Serratia infection preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Skin and skin structure Serratia infection.

A skin and skin structure Serratia infection is a bacterial infection of the epidermis, dermis, or deeper subcutaneous tissues caused by species of the genus *Serratia*, most frequently the opportunistic Gram-negative bacillus *Serratia marcescens*.

Primarily encountered in healthcare settings, these infections typically affect hospitalized, postoperative, or immunocompromised individuals, as well as patients with disrupted cutaneous barriers or indwelling medical devices.

Pathophysiologically, the organism invades damaged integumentary tissues and incites an inflammatory response that can present clinically as cellulitis, cutaneous abscesses, nonhealing ulcers, or surgical wound infections, with the potential to progress to invasive, necrotizing soft-tissue disease.

Personalize your experience

Follow Skin and skin structure Serratia infection and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it